| General Information of Drug Metabolite (DM) (ID: DM000376) |
| DM Name |
N-acetylsufapyridine
|
|
|
|
|
|
|
|
| Full List of Drug-Metabolizing Enzyme (DME) Related to This DM |
| DME(s) Producing This DM through Metabolism |
| DME Name |
DME ID |
Reactant |
Reaction |
Related Drug |
REF |
|
N-acetyltransferase 2 (NAT2)
|
DME0051
|
| Conjugation - Acetylation |
Sulfapyridine
|
[1] |
|
N-acetyltransferase 2 (NAT2)
|
DME0051
|
| Conjugation - Acetylation |
Sulfasalazine
|
[1] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Full List of Drug(s) That Produce This DM By Metabolism |
| Sulfasalazine |
DR1513
|
Approved |
Rheumatoid arthritis |
|
|
| Sulfapyridine |
DR1512
|
Approved |
Dermatitis herpetiformis |
|
|
| References |
| 1 |
Effects of NAT2 polymorphism on SASP pharmacokinetics in Chinese population. Clin Chim Acta. 2009 Sep;407(1-2):30-5.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
